Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTID (Q40158875)
Jump to navigation
Jump to search
scientific article published on 14 March 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTID |
scientific article published on 14 March 2007 |
Statements
Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTIDC) (English)
Toshifumi Kimura
Akio Satow
Naoki Kaneko
Junko Fukuda
Hirohiko Hikichi
Naoko Sakai
Shunsuke Maehara
Hiroko Kawagoe-Takaki
Mikiko Hata
Tomoko Azuma
Satoru Ito
Hiroshi Kawamoto
Hisashi Ohta
14 March 2007